Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
supporting study
Study period:
1996
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study meets generally accepted scientific principles and considered sufficiently reliable for the purpose of hazard assessment.
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1996

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Principles of method if other than guideline:
Skin prick test according to Malling (1993) - Commercial and in-house allergenic extracts from Cupressaceae family were used for skin prick testing and specific IgE detection in six groups of subjects exposed to a high concentration of Cupressaceae pollen.
GLP compliance:
no

Test material

Constituent 1
Reference substance name:
Automatically generated during migration to IUCLID 6, no data available
IUPAC Name:
Automatically generated during migration to IUCLID 6, no data available
Test material form:
not specified
Details on test material:
- Name of test material (as cited in study report): Cupressaceae pollen

Method

Type of population:
general
Ethical approval:
confirmed and informed consent free of coercion received
Subjects:
- Number of subjects exposed: 713
- Sex: Male and female
- Age: 2-82 years (mean ± SD, 28.5 ± 17.1; median value 26)
Clinical history:
- Patients included were those complaining of symptoms related to upper or lower respiratory tract disorders or conjunctival disease, all suspected of being allergic in nature.
Controls:
- Positive and negative controls were histamine solution (10 mg/mL) and 50 % glycerinated solution in water, respectively.
Route of administration:
dermal
Details on study design:
- Skin prick tests were performed according to standard procedure (Malling, 1993).
- Commercial and in-house allergenic extracts were used for skin prick testing and specific IgE detection in six groups of subjects exposed to a high concentration of Cupressaceae pollen.
- Specific IgE detection was performemed according to the procedure (Bousquet et al., 1990; Kleine-Tebbe et al., 1992; Merret et al., 1993; Olivieri et al., 1993; Salkie et al., 1994)
- Patients were asked to avoid antihistamine intake for at least 7 days before testing (8 weeks for astemizole). Test evaluation was done after 15 minutes.

Results and discussion

Results of examinations:
- Positive response: Sensitization effects, 31.5 % of the patients had positive responses to the in-house extract of the test material; 25.9 % had positive responses to the commercial extract.
- Four commercial and two in-house Cupressus sempervirens pollen extracts showed low cutaneous reactivity.
- Positive test results were recorded in 26 % of the 713 subjects tested. C. arizonica in-house pollen extracts gave rise to larger cutaneous reactions. Furthermore, the skin prick test response was positive in a greater number of subjects (38 %) of the same group.
- Six commercial immunoassays were able to detect specific IgE to C. sempervirens in rates ranging from 8.1% to 81.1%. Specific IgE to C. arizonica was detected by means of an in-house immunoenzymatic method in 70.3% of 54 patients with suspected "cypress" allergy, and specific IgE to C. sempervirens was detected in 75.9% of these patients by using a commercial system.
- High rates of cross-reactivity within the Cupressaceae family were recorded with both in vivo and in vitro tests.

Any other information on results incl. tables

None

Applicant's summary and conclusion

Conclusions:
Under the test condition, Cupressaceae pollen induced skin sensitization in human.
Executive summary:

Skin prick test was conducted in 713 male and female patients with Cupressaceae pollen.

Sensitization effects were observed: 31.5% of the patients had positive responses to the in-house extract of the test material; 25.9% had positive responses to the commercial extract.

Under the test condition, Cupressaceae pollen induced skin sensitization in human.